Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

At present, there is no universal definition of rare disease.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Value Health

Title: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

ISSN (Electronic): 1524-4733

ISSN (Print): 1098-3015

Publication date (Electronic): Sep 2015

Volume: 18

Issue: 6

Affiliations

[1 ] Canadian Agency for Drugs & Technologies in Health (CADTH), Ottawa, Ontario, Canada. Electronic address: trevorr@cadth.ca.

[2 ] Roboleo & Co, York, UK.

[3 ] St. Elizabeth University, Bratislava, Slovakia.

[4 ] Celgene Corporation, Summit, NJ, USA.

[5 ] International Society for Pharmacoeconomics and Outcomes Research (ISPOR), South Lawrenceville, NJ, USA.

[6 ] Center for Health Economics and Medicines Evaluation, Bangor University, Wales, UK.

Article

Publisher Item ID: S1098-3015(15)01979-8

DOI: 10.1016/j.jval.2015.05.008

PubMed ID: 26409619

SO-VID: ae3fc000-4454-4bf5-a70c-f5ede48dbf63

History

Keywords: orphan drugs,prevalence,rare disease,terminology

Data availability:

Keywords: orphan drugs, prevalence, rare disease, terminology

Comments

Comment on this article

scite_

Cited by 138

See all cited by

- Version 1